R. Balena

A direct comparison of long‐ and short‐acting GLP‐1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment

J. Rosenstock, A. Gastaldelli, B. Charbonnel, 2014, Diabetes, obesity & metabolism.